Anna Sanchez, DPM
NPI 1881780468 · Podiatrist · San Antonio, TX
Enrolled with Medicare as Practitioner - Podiatry · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1881780468
- Entity type
- Individual
- Primary specialty
- PodiatristPodiatric Medicine & Surgery Service Providers
- Credential
- DPM
- Sex
- Female
- Sole proprietor
- No
- License
- 1292 (TX)
Specialties & taxonomies
Podiatric Medicine & Surgery Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
4,495 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Nucleic Acid for Organism, Amplified Probe Technique87798 | 2,496 | $34 |
| Detection Test By Nucleic Acid for Multiple Organisms, Amplified Probe(s) Technique87801 | 540 | $69 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 508 | $87 |
| Detection Test By Nucleic Acid for Staphylococcus Aureus (bacteria), Amplified Probe Technique87640 | 191 | $34 |
| Detection Test By Nucleic Acid for Vancomycin Resistance Strep (vre), Amplified Probe Technique87500 | 180 | $34 |
| Detection Test By Nucleic Acid for Staphylococcus Aureus, Methicillin Resistant (mrsa Bacteria), Amplified Probe Technique87641 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Mupirocin | 90 | 37 |
| Ketoconazole | 66 | 28 |
| Collagenase Clostridium Hist.brand: Santyl | 40 | 27 |
| Ciprofloxacin Hcl | 34 | 21 |
| Linezolid | 25 | 16 |
| Levofloxacin | 13 | — |
| Becaplerminbrand: Regranex | 12 | — |
| Naltrexone Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$3,190 across 22 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 1901 Babcock Rd Ste 102San Antonio, TX 78229-4544Phone: (210) 872-3668Fax: (210) 428-6317
Registry dates
- Enumerated
- 2006-10-04
- Last updated
- 2022-11-01
- Certified
- 2022-11-01
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.